Case report: complete response lasting for 10+ years in a BRCA2 carrier, whose advanced non-small cell lung cancer was treated by the combination of mitomycin C, cisplatin and vincristine. This evidence concerns the gene BRCA2 and non-small cell lung carcinoma.